Discovery of new biomarkers for malignant mesothelioma

Por Creaney, Jenette, Dick, Ian M., Robinson, Bruce W. S.
Publicado no Curr Pulmonol Rep (2015)

The continual search for ideal biomarkers for mesothelioma: the hurdles

Por Brims, Fraser J, Lee, Y C Gary, Creaney, Jenette
Publicado em 2013

A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ

Por CREANEY, JENETTE, DICK, IAN M, LEON, JUSTINE S, ROBINSON, BRUCE W.S
Publicado no Cancer Genomics Proteomics (2017)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma

Por Creaney, Jenette, Dick, Ian M., Yeoman, Deborah, Wong, Sarah, Robinson, Bruce W. S.
Publicado em 2011

Association of Biomarker Levels with Severity of Asbestos-Related Diseases

Por Park, Eun-Kee, Yates, Deborah H, Creaney, Jenette, Thomas, Paul S, Robinson, Bruce W, Johnson, Anthony R
Publicado em 2012

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo

Por Greening, David W., Ji, Hong, Chen, Maoshan, Robinson, Bruce W. S., Dick, Ian M., Creaney, Jenette, Simpson, Richard J.
Publicado no Sci Rep (2016)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma

Por Creaney, Jenette, Segal, Amanda, Olsen, Nola, Dick, Ian M., Musk, A. W(Bill), Skates, Steven J., Robinson, Bruce W.
Publicado no Dis Markers (2014)

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Por Morré, D. James, Hostetler, Brandon, Taggart, David J., Morré, Dorothy M., Musk, A. W., Robinson, Bruce W. S., Creaney, Jenette
Publicado no Clin Proteomics (2016)

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Por Morré, D. James, Hostetler, Brandon, Taggart, David J., Morré, Dorothy M., Musk, A. W., Robinson, Bruce W. S., Creaney, Jenette
Publicado no Clin Proteomics (2016)

Interleukin-5 Transgenic Mice Show Enhanced Resistance to Primary Infections with Nippostrongylus brasiliensis but Not Primary Infections with Toxocara canis

Por Dent, Lindsay A., Daly, Christine M., Mayrhofer, Graham, Zimmerman, Trudy, Hallett, Ann, Bignold, Leon P., Creaney, Jenette, Parsons, Jim C.
Publicado em 1999

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum

Por Creaney, Jenette, Sneddon, Sophie, Dick, Ian M., Dare, Hanne, Boudville, Neil, Musk, Arthur William, Skates, Steven J., Robinson, Bruce W. S.
Publicado em 2013

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma

Por Robinson, Cleo, Dick, Ian M., Wise, Michael J., Holloway, Andrew, Diyagama, Dileepa, Robinson, Bruce W. S., Creaney, Jenette, Lake, Richard A.
Publicado no BMC Cancer (2015)

Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis

Por Lim, Chuan Bian, Prêle, Cecilia M., Baltic, Svetlana, Arthur, Peter G., Creaney, Jenette, Watkins, D. Neil, Thompson, Philip J., Mutsaers, Steven E.
Publicado no Oncotarget (2015)

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

Por Creaney, Jenette, Yeoman, Deborah, Naumoff, Leanne K, Hof, Michelle, Segal, Amanda, Musk, Arthur William, De Klerk, Nicholas, Horick, Nora, Skates, Steven J, Horick, Bruce W S RobinsonNora
Publicado em 2007

Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells

Por Varano della Vergiliana, Julius F., Lansley, Sally M., Porcel, Jose M., Bielsa, Silvia, Brown, Jeremy S., Creaney, Jenette, Temple, Suzanna E. L., Waterer, Grant W., Lee, Y. C. Gary
Publicado em 2013

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Por Creaney, Jenette, Dick, Ian M, Meniawy, Tarek M, Leong, Su Lyn, Leon, Justine S, Demelker, Yvonne, Segal, Amanda, (Bill) Musk, A W, Lee, Y C Gary, Skates, Steven J, Nowak, Anna K, Robinson, Bruce W S
Publicado em 2014

Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endor...

Por Hjerpe, Anders, Ascoli, Valeria, Bedrossian, Carlos, Boon, Mathilde, Creaney, Jenette, Davidson, Ben, Dejmek, Annika, Dobra, Katalin, Fassina, Ambrogio, Field, Andrew, Firat, Pinar, Kamei, Toshiaki, Kobayashi, Tadao, Michael, Claire W., Önder, Sevgen, Segal, Amanda, Vielh, Philippe
Publicado no Cytojournal (2015)

Transient Treg depletion enhances therapeutic anti‐cancer vaccination

Por Fisher, Scott A., Aston, Wayne J., Chee, Jonathan, Khong, Andrea, Cleaver, Amanda L., Solin, Jessica N., Ma, Shaokang, Lesterhuis, W. Joost, Dick, Ian, Holt, Robert A., Creaney, Jenette, Boon, Louis, Robinson, Bruce, Lake, Richard A.
Publicado no Immun Inflamm Dis (2016)

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen

Por Creaney, Jenette, Ma, Shaokang, Sneddon, Sophie A, Tourigny, Michelle R, Dick, Ian M, Leon, Justine S, Khong, Andrea, Fisher, Scott A, Lake, Richard A, Lesterhuis, W Joost, Nowak, Anna K, Leary, Shay, Watson, Mark W, Robinson, Bruce W
Publicado no Oncoimmunology (2015)

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Por Bott, Matthew, Brevet, Marie, Taylor, Barry S, Shimizu, Shigeki, Ito, Tatsuo, Wang, Lu, Creaney, Jenette, Lake, Richard A, Zakowski, Maureen F, Reva, Boris, Sander, Chris, Delsite, Robert, Powell, Simon, Zhou, Qin, Shen, Ronglai, Olshen, Adam, Rusch, Valerie, Ladanyi, Marc
Publicado no Nat Genet (2011)